Kumar, A.H. 2021. Network Pharmacology Analysis of Orally Bioavailable SARS-CoV-2 Protease Inhibitor Shows Synergistic Targets to Improve Clinical Efficacy. Biology, Engineering, Medicine and Science Reports. 7, 2 (Oct. 2021), 21–24. DOI:https://doi.org/10.5530/bems.7.2.8.